Immuno-Pharmacology and Interactomics

Websitehttps://www.lih.lu/en/research-scope/research-department/department-of-infection-and-immunity/immuno-pharmacology-and-interactomics/

10 Finished
11 Active

21 results

Active
CANBIO2 (Joy Darcis): Targeting the atypical chemokine receptor ACKR3 for improved cancer therapy
Chevigne, A. & Darcis, J.
FNR - Fonds National de la Recherche
15/10/23 → 14/10/27
Project: Research
NanoLux: NanoLux Platform Mobility to Quebec
Chevigne, A. & Szpakowska, M.
1/09/23 → 31/08/26
Project: Research
HOPE-IOID: Multilevel regulation and modulation of the new opioid peptide scavenger ACKR3
Chevigne, A. & Cassano, E.
1/03/23 → 28/02/27
Project: Research
Nextimmune-2 (Ana Alonso Bartolomé): Unravelling the multidimensional regulation of the chemokine functions in health and disease with network-wide approaches
Chevigne, A., Szpakowska, M. & Alonso Bartolomé, A.
FNR - Fonds National de la Recherche
1/01/23 → 31/12/25
Project: Research
NanoLux platform: NanoLux platform
Chevigne, A. & Szpakowska, M.
Luxembourg Institute of Health
1/01/23 → 31/12/24
Project: Research
Conolidine (TLV-2022-PDR): Regulation of glioblastoma growth and tumor microenvironment by receptors ACKR3 and CXCR4
Szpakowska, M. & Chevigne, A.
1/10/22 → 30/09/24
Project: Research
EVceptor: Role of chemokine receptor-bearing extracellular vesicles in leukaemia and lymphoma
Chevigne, A., Paggetti, J., Szpakowska, M. & Bonnemain-Pascual, H.
FNRS - Fonds National de la Recherche Scientifique
1/05/22 → 30/04/24
Project: Research
ACKR3/CXCL12 axis in GBM: Study of the CXCL12-CXCR4/ACKR3 signaling in glioblastoma and of its importance in the control of translation and relapses
Chevigne, A. & Rogister, B.
FNR - Fonds National de la Recherche
3/05/21 → 30/05/25
Project: Research
I2TRON Rafael Luis: Development of chemokine receptor modulators for improved cancer immunotherapy
Chevigne, A. & Luis, R.
FNR - Fonds National de la Recherche
1/03/21 → 28/02/25
Project: Research
Opiokine: Multidimensional regulation of the opioid network by ACKR3
Palmer, C., Chevigne, A. & Szpakowska, M.
FNR - Fonds National de la Recherche
15/05/20 → 14/05/24
Project: Research
SMART GLIOBLASTOMA: SMART GLIOBLASTOMA: Signaling and Modulation of the AtypicalIsoform of the CXCR3 RecepTor in glioblastoma cells
Chevigne, A., Niclou, S., Rogister, B., Hanson, J. & D'Uonnolo, G.
FNRS - Fonds National de la Recherche Scientifique
15/05/20 → 14/10/24
Project: Research
Finished
MEGAKINE: Megakines - novel tools for structural insight into receptor:chemokine complexes
Uchanski, T. & Chevigne, A.
European Commission
1/09/21 → 4/01/22
Project: Research
EXOKINE (ACKR3/CXCR7): Unraveling the role of the ACKR3/CXCR7 receptor in glioblastoma cells survival and invasion in the tumor relapse.
Rogister, B., Chevigne, A. & Szpakowska, M.
FNRS - Fonds National de la Recherche Scientifique
1/07/21 → 30/11/23
Project: Research
NanoLux SARS-CoV-2: Assessment of SARS-CoV-2neutralizing antibodies inLuxembourg through novel highlysensitive NanoLuciferase-basedhigh throughput assays
Chevigne, A. & Ollert, M.
FNR - Fonds National de la Recherche, Laboratoires Réunis S.A.
1/09/20 → 14/07/23
Project: Research
MEGAKINE: Megakines - novel tools for structural insight into receptor:chemokine complexes
Chevigne, A., Uchanski, T. & Counson, M.
FNR - Fonds National de la Recherche
1/03/20 → 28/02/22
Project: Research
ACKR2 (CHEMOKINE RECEPTORS AND IMMUNOTHERAPY): Targeting chemokine receptors: An innovative strategy to reprogram cold to hot tumor microenvironment and to improve PD-1-based cancer immunotherapy
Janji, B. & Chevigne, A.
Lions Clubs International, FNRS - Fonds National de la Recherche Scientifique
1/03/20 → 28/02/22
Project: Research
INTERceptor: Targeting chemokine receptors for improved cancer immunotherapy
Szpakowska, M., Chevigne, A. & Janji, B.
FNR - Fonds National de la Recherche
1/12/19 → 31/07/20
Project: Research
LIH383: Evaluation of LIH383 as a new neuro-pharmacological modulator
Chevigne, A., Langlet, J. & Szpakowska, M.
FNR - Fonds National de la Recherche
1/03/19 → 14/11/19
Project: Research
NEXTIMMUNE (Nathan Reynders): Validation of chemokine receptor isoforms as drug targets for cancer therapy using Nanobody technology
Chevigne, A. & Reynders, N.
FNR - Fonds National de la Recherche
1/01/17 → 31/12/20
Project: Research
Nanokine: Nanobody-enabled structural and functional studies of Chemokine-CCR5 active-state complexes
Chevigne, A. & Steyaert, J.
FNR - Fonds National de la Recherche
1/03/16 → 29/05/20
Project: Research
CX-CRP-73: Expression and functional characterization of the CXCR3-CXCR7heterodimer in glioblastoma
Chevigne, A. & Hanson, J.
FNRS - Fonds National de la Recherche Scientifique
1/10/15 → 31/07/18
Project: Research